Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients.
Farhangfar CJ, Scarola GT, Morris VA, Farhangfar F, Dumas K, Symanowski J, Hwang JJ, Mileham KF, Carrizosa DR, Naumann RW, Livasy C, Kim ES, Raghavan D. Farhangfar CJ, et al. Among authors: mileham kf. JCO Clin Cancer Inform. 2022 Jul;6:e2200011. doi: 10.1200/CCI.22.00011. JCO Clin Cancer Inform. 2022. PMID: 35839431 Free article.
Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
Silvestri GA, Tanner NT, Kearney P, Vachani A, Massion PP, Porter A, Springmeyer SC, Fang KC, Midthun D, Mazzone PJ; PANOPTIC Trial Team. Silvestri GA, et al. Chest. 2018 Sep;154(3):491-500. doi: 10.1016/j.chest.2018.02.012. Epub 2018 Mar 1. Chest. 2018. PMID: 29496499 Free PMC article.
New targets and new mechanisms in lung cancer.
Carrizosa DR, Mileham KF, Haggstrom DE. Carrizosa DR, et al. Among authors: mileham kf. Oncology (Williston Park). 2013 May;27(5):396-404. Oncology (Williston Park). 2013. PMID: 25184262 Free article. Review.
Efficacy and Safety Results of the Afatinib Expanded Access Program.
Kim ES, Halmos B, Kohut IF, Patel T, Rostorfer RD, Spira AI, Cseh A, McKay J, Wallenstein G, Mileham KF. Kim ES, et al. Among authors: mileham kf. Oncol Ther. 2017;5(1):103-110. doi: 10.1007/s40487-017-0043-5. Epub 2017 Apr 10. Oncol Ther. 2017. PMID: 28680960 Free PMC article.
Initial Results from Mobile Low-Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved Populations.
Raghavan D, Wheeler M, Doege D, Doty JD 2nd, Levy H, Dungan KA, Davis LM, Robinson JM, Kim ES, Mileham KF, Oliver J, Carrizosa D. Raghavan D, et al. Among authors: mileham kf. Oncologist. 2020 May;25(5):e777-e781. doi: 10.1634/theoncologist.2019-0802. Epub 2019 Nov 26. Oncologist. 2020. PMID: 31771991 Free PMC article.
38 results